An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen speciesopen access
- Authors
- Lee, C.M.[Lee, C.M.]; Kang, M.-A.[Kang, M.-A.]; Bae, J.S.[Bae, J.S.]; Park, K.[Park, K.]; Yang, Y.-H.[Yang, Y.-H.]; Lee, J.[Lee, J.]; Jang, K.Y.[Jang, K.Y.]; Park, S.-H.[Park, S.-H.]
- Issue Date
- Mar-2022
- Publisher
- SAGE Publications Ltd
- Keywords
- apoptosis; ovarian cancer; reactive oxygen species; Remdesivir
- Citation
- Human and Experimental Toxicology, v.41
- Indexed
- SCIE
SCOPUS
- Journal Title
- Human and Experimental Toxicology
- Volume
- 41
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/97252
- DOI
- 10.1177/09603271221089257
- ISSN
- 0960-3271
- Abstract
- Background: Remdesivir is an anti-viral drug that inhibits RNA polymerase. In 2020, remdesivir was recognized as the most promising therapeutic agents against coronavirus disease 2019 (COVID-19). However, the effects of remdesivir on cancers have hardly been studied. Purpose: Here, we reported that the anti-carcinogenic effect of remdesivir on SKOV3 cells, one of human ovarian cancer cell lines. Research design: We anlalyzed the anti-carcarcinogenic effect of remdesivir in SKOV3 cells by performing in vitro cell assay and western blotting. Results: WST-1 showed that remdesivir decreased cell viability in SKOV3 cells. Experiments conducted by Muse Cell Analyzer showed that remdesivir-induced apoptosis in SKOV3 cells. We found that the expression level of FOXO3, Bax, and Bim increased, whereas Bcl-2, caspase-3, and caspase-7 decreased by remdesivir in SKOV3 cells. Furthermore, we observed that intracellular reactive oxygen species (ROS) level increased after treatment of remdesivir in SKOV3 cells. Interestingly, cytotoxicity of remdesivir decreased after treatment of N-Acetylcysteine. Conclusion: Taken together, our results demonstrated that remdesivir has an anti-carcinogenic effect on SKOV3 cells vis up-regulation of reactive oxygen species, which suggests that remdesivir could be a promising reagent for treatment of ovarian cancer. © The Author(s) 2022.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Biotechnology and Bioengineering > Integrative Biotechnology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/97252)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.